Press release
Evolving Market Trends In The Intravenous Immunoglobulin Industry: GC Pharma Launches Innovative Liquid Immune Globulin Formulation For Immunodeficiency Treatment
Intravenous Immunoglobulin
What Is the Expected Intravenous Immunoglobulin Market Size During the Forecast Period?
In recent years, the intravenous immunoglobulin market has experienced significant expansion. Its growth is projected to increase from $14.66 billion in 2024 to $15.72 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. This historic growth can be credited to factors such as the treatment of primary immunodeficiency diseases, the management of neurological disorders, an increasing elderly population, advances in plasma fractionation methods, extended applications in neurology, and the treatment of infectious diseases and pediatric immunodeficiency.
The size of the intravenous immunoglobulin market is predicted to experience significant expansion in the upcoming years, with projections indicating a growth to $22.01 billion by 2029 at a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this anticipated growth during the forecast period include the rising incidence of autoimmune disorders, ongoing immunology research, increased healthcare spending, a rise in cancer cases, advancements in immunoglobulin products, and the utilization of personalized medicine tactics. Key trends expected during this future period encompass treatment of primary immunodeficiency disorders (PIDD), rapid technological evolution, strategic alliances and collaborations, advancements in manufacturing methods, neurology indications, hematology application, and progression in immunotherapy.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8538
What Are the High-Growth Segments in the Intravenous Immunoglobulin Market?
The intravenous immunoglobulin market covered in this report is segmented -
1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
4) By End-User: Hospitals, Clinics, Home Care
Subsegments:
1) By Immunoglobulin G (IgG): Normal IgG, Specific IgG
2) By Immunoglobulin M (IgM): Normal IgM, Specific IgM
3) By Immunoglobulin A (IgA): Normal IgA, Specific IgA
4) By Immunoglobulin E (IgE): Normal IgE, Specific IgE
5) By Immunoglobulin D (IgD): Normal IgD, Specific IgD
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp
What Key Drivers Are Expected to Influence Future Intravenous Immunoglobulin Market Growth?
The rise in the elderly population is anticipated to propel the growth of the intravenous immunoglobulin market. The term elderly population refers to individuals who are aged 65 years and above. As people age, their immunity systems diminish, reducing the production of antibodies. Consequently, they require immunoglobulins to supplement these antibodies. This results in a boost in demand for intravenous immunoglobulins and propels the intravenous immunoglobulin market. For instance, the Population Reference Bureau, a nonprofit organization based in Kenya, projected in January 2024 that the number of Americans aged 65 and above will increase from 58 million in 2022 to 82 million by 2050, showcasing a 47% rise. The percentage of this age group in the total population is also expected to increase from 17% to 23% within the same timeframe. Therefore, the growth of the elderly population is set to accelerate the growth of the intravenous immunoglobulin market.
Which Companies Hold the Largest Share Across Different Intravenous Immunoglobulin Market Segments?
Major companies operating in the intravenous immunoglobulin market are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.
What Trends Are Driving Growth in The Intravenous Immunoglobulin Market?
In the world of intravenous immunoglobulin market, product innovation is a significant trend that is gaining traction. Major firms in this sector are making strides in new product advancement, focusing on creations such as liquid immune globulin formulations that can treat immunodeficiency diseases. Their aim is to solidify their market standing. An example of this is seen when GC Pharma, a pharmaceutical company based in South Korea, in December 2023, unveiled Alyglo, a product with the approval of the US Food and Drug Administration (FDA). Alyglo, a sterile, ready-to-use liquid formulation, contains 10% immunoglobulin G (IgG), offering 100 mg/mL of protein where at least 96% is human IgG extracted from pooled human plasma. The drug is specifically designed for adults 17 years and older living with primary humoral immunodeficiency (PI). It addresses conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
What Are the Emerging Geographies for The Intravenous Immunoglobulin Market Growth?
North America was the largest region in the intravenous immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Intravenous Immunoglobulin Market?
2. What is the CAGR expected in the Intravenous Immunoglobulin Market?
3. What Are the Key Innovations Transforming the Intravenous Immunoglobulin Industry?
4. Which Region Is Leading the Intravenous Immunoglobulin Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Evolving Market Trends In The Intravenous Immunoglobulin Industry: GC Pharma Launches Innovative Liquid Immune Globulin Formulation For Immunodeficiency Treatment here
News-ID: 3970837 • Views: …
More Releases from The Business Research Company
2025-2034 Mainframe Modernization Market Evolution: Emerging Opportunities and M …
What Is the Projected Size of the Mainframe Modernization Market by 2025?
Recent years have witnessed substantial expansion in the market dedicated to mainframe modernization, with projections indicating a climb from a valuation of $15.72 billion in 2024 up to $18.12 billion by 2025, a trajectory translating to a compound annual growth rate (CAGR) of 15.2%. This historical upward trend is fueled by several key factors, chief among them being escalating…
Accelerated Digital Transformation Fuels Expansion in the Liquid Crystal Polymer …
How Much Will the Liquid Crystal Polymer (LCP)-Based Molded Interconnect Device Market Size Increase by 2025?
The market for liquid crystal polymer (LCP)-based molded interconnect devices has experienced swift augmentation recently, projected to escalate from a value of $0.64 billion in 2024 to $0.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.3%. This historical expansion is largely traceable to several key factors, including the wider acceptance of…
Consistent Growth Projected for Land-Based Command, Control, Communications, Com …
How Much Is the Land-Based Command, Control, Communications, Computers, Intelligence, Surveillance, And Reconnaissance( C4ISR ) Market Expected to Expand by 2025?
The terrestrial C4ISR sector has experienced robust expansion lately, projected to increase its valuation from $32.64 billion in 2024 to $34.87 billion the following year, reflecting a steady compound annual growth rate of 6.8%. This upward trajectory in the past phase is traceable to several key factors, including a more…
Surging Application Across End Users Powers the Expansion of the Intelligent Ele …
How Large Is the Intelligent Electrical Panel Market Expected to Be by 2025?
The electrical panel segment characterized by intelligence has experienced swift expansion recently, projected to escalate its valuation from a total of $4.47 billion in the year 2024 to $4.95 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%; this upward trajectory throughout the preceding period is linked to several factors, namely the escalating need for…
More Releases for Immunoglobulin
Immunoglobulin Market Forecast 2035 | Advancing Therapeutic Outcomes: Growth of …
An extensive study of propelling opportunities in, "Immunoglobulin Market Size, Share & Trends Analysis Report by Product Type (IgG, IgA, IgM, IgE, IgD), Form, Route of Administration, Application, Source, Technology, Therapy Type, Patient Demographics, End-user / Distribution Channel and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A comprehensive report of growing market landscapes in the immunoglobulin sector…
Rabies Immunoglobulin Market - Dynamics and Growth Pattern
The "Rabies Immunoglobulin Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Rabies Immunoglobulin Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leading…
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements …
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate?
There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,…
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South…
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,…
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of…
